Your browser doesn't support javascript.
loading
Evaluation of partial volume correction and analysis of longitudinal [18F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models.
Sanabria Bohórquez, Sandra M; Baker, Suzanne; Manser, Paul T; Tonietto, Matteo; Galli, Christopher; Wildsmith, Kristin R; Zou, Yixuan; Kerchner, Geoffrey A; Weimer, Robby; Teng, Edmond.
  • Sanabria Bohórquez SM; Clinical Imaging Group, Genentech, Inc., South San Francisco, CA, United States.
  • Baker S; Clinical Imaging Group, Genentech, Inc., South San Francisco, CA, United States.
  • Manser PT; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, United States.
  • Tonietto M; Biostatistics, Genentech, Inc., South San Francisco, CA, United States.
  • Galli C; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Wildsmith KR; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Zou Y; Biomarker Development, Genentech, Inc., South San Francisco, CA, United States.
  • Kerchner GA; Data and Statistical Science, Product Development, Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Weimer R; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Teng E; Translational Imaging, Genentech, Inc., South San Francisco, CA, United States.
Front Neuroimaging ; 3: 1355402, 2024.
Article en En | MEDLINE | ID: mdl-38606196
ABSTRACT

Purpose:

We evaluated the impact of partial volume correction (PVC) methods on the quantification of longitudinal [18F]GTP1 tau positron-emission tomography (PET) in Alzheimer's disease and the suitability of describing the tau pathology burden temporal trajectories using linear mixed-effects models (LMEM).

Methods:

We applied van Cittert iterative deconvolution (VC), 2-compartment, and 3-compartment, and the geometric transfer matrix plus region-based voxelwise methods to data acquired in an Alzheimer's disease natural history study over 18 months at a single imaging site. We determined the optimal PVC method by comparing the standardized uptake value ratio change (%ΔSUVR) between diagnostic and tau burden-level groups and the longitudinal repeatability derived from the LMEM. The performance of LMEM analysis for calculating %ΔSUVR was evaluated in a natural history study and in a multisite clinical trial of semorinemab in prodromal to mild Alzheimer's disease by comparing results to traditional per-visit estimates.

Results:

The VC, 2-compartment, and 3-compartment PVC methods had similar performance, whereas region-based voxelwise overcorrected regions with a higher tau burden. The lowest within-subject variability and acceptable group separation scores were observed without PVC. The LMEM-derived %ΔSUVR values were similar to the per-visit estimates with lower variability.

Conclusion:

The results indicate that the tested PVC methods do not offer a clear advantage or improvement over non-PVC images for the quantification of longitudinal [18F]GTP1 PET data. LMEM offers a robust framework for the longitudinal tau PET quantification with low longitudinal test-retest variability. Clinical trial registration NCT02640092 and NCT03289143.
Palabras clave